54 results
8-K
ATHA
Athira Pharma Inc
15 May 24
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
4:10pm
-releases). The Company uses these channels, as well as social media, including its X account (formerly known as Twitter)(@athirapharma), LinkedIn
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
Communications with the Board of Directors
Policy Prohibiting Hedging or Pledging of Securities
Code of Business Conduct and Ethics
Environmental, Social … regarding our risks, including credit risks, liquidity risks, environmental, social and governance (“ESG”) related risks, cybersecurity risks
8-K
EX-10.1
5bsnqfr5
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
d6bgtte7mr zvhix0
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.1
4b4qdcdeyvii85c19
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
w4t8ktts0nfsl4sgu
9 Nov 23
Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
m5ac5nf0
10 Aug 23
Athira Pharma Reports Second Quarter 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
fosuj5lwxy47iq4texx1
11 May 23
Athira Pharma Reports First Quarter 2023 Financial Results
4:11pm
8-K
nm74o5zz omjndd
10 Nov 22
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:11pm
8-K
EX-99.2
r2g9hngsn9
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
fltjldjkyqhq wbjy
15 Aug 22
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:35pm